{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "M",
          "alt": "L",
          "position": "133"
        },
        "variant_string_id": "SNCA M133L"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson's disease is characterized by the accumulation of a-synuclein protein aggregates.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the accumulation of a-synuclein protein aggregates."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses a recombinant a-synuclein protein aggregation assay.",
          "judgment": "Yes",
          "reasoning": "The paper states that the assay is used to model the disease mechanism."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study includes basic controls and replicates for the assay.",
          "judgment": "Yes",
          "reasoning": "The paper states that basic controls were included and multiple replicates were used."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The study calculates an OddsPath value for the M133L variant.",
          "judgment": "Yes",
          "reasoning": "The paper states that an OddsPath value was calculated."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The M133L variant is likely pathogenic based on the strong evidence from the recombinant a-synuclein protein aggregation assay, which showed a moderate increase in OddsPath."
    }
  ]
}